News & Events


Recent Firm Activities and Highlights

What is Hospital Charge Reconciliation?
09.15.20
Working in and around revenue cycle technology for so long, we often communicate about features and benefits in shorthand. With so many different types of health information solutions, ownership models, service lines and so forth, sometimes we talk about things in an unknown, or jargon-y language without even realizing it. Take charge reconciliation as an example. At medaptus this means the act of confirming that for every visit and/or service delivered, a charge exists. When it doesn’t, this is evident and actionable. Charge reconciliation is vital to all of our products. Read Full Release
IBM Watson Health and OrbitalRX to Launch Integrated Solution to Assist Hospital Pharmacy Providers in Managing Drug Shortages
09.01.20
IBM (NYSE: IBM) Watson Health and OrbitalRX® today announced a strategic collaboration that aims to help address the emerging drug shortage crisis. The companies are combining OrbitalRX's Drug Shortage Management Platform and IBM® Micromedex® into one unified solution called "OrbitalRX and Micromedex," designed to create a single source for healthcare providers and pharmacy teams to access evidence-based treatment information alongside a hospital's current drug inventory status and drug sourcing options. This one solution aims to quickly analyze the supply chain and identify clinical alternatives for drugs that are in short supply. Read Full Release
Boston Millennia Parters
Digital Diagnostics, formerly IDx, Expands Global Impact of Healthcare Autonomous AI with Acquisition of 3Derm Systems, Inc.
08.23.20
Healthcare access and inequity challenges have been exacerbated by the COVID-19 pandemic; members of at-risk populations around the world are increasingly delaying important specialist care. Today Digital Diagnostics Inc., a pioneering global healthcare autonomous artificial intelligence (AI) company formerly known as IDx, announces it has acquired 3Derm Systems, Inc. of Boston, MA. This acquisition makes Digital Diagnostics the global leader in healthcare autonomous AI, where it is the sole holder of autonomous AI healthcare systems that are De Novo authorized by the U.S. Food & Drug Administration (FDA), enabling the company to close more care gaps widened by COVID-19. Read Full Release
medaptus Celebrates 20 Years of Health Technology Innovation
08.23.20
For 20 years medaptus has applied information technology to solve problems that are common and costly to healthcare organizations. To mark its twentieth anniversary, the company recently provided an update on its extensive technology capabilities grounded in interoperability. Read Full Release
Boston Millennia Parters
EY Announces David Weingard of Cecelia Health as an Entrepreneur Of The Year® 2020 New York Award Finalist
08.19.20
Ernst & Young LLP (EY US) has announced that David Weingard, CEO and Founder of Cecelia Health, was named an Entrepreneur Of The Year® 2020 New York Award finalist. Now in its 34th year, the Entrepreneur Of The Year program honors entrepreneurial business leaders whose ambitions deliver innovation, growth and prosperity as they build and sustain successful businesses that transform our world. David was selected as one of the finalists by a panel of independent judges comprising former winners and business leaders from multiple industries. Read Full Release
Boston Millennia Parters
Digital Diagnostics, formerly IDx, Expands Global Impact of Healthcare Autonomous AI with Acquisition of 3Derm Systems, Inc.
08.19.20
Healthcare access and inequity challenges have been exacerbated by the COVID-19 pandemic; members of at-risk populations around the world are increasingly delaying important specialist care. Today Digital Diagnostics Inc., a pioneering global healthcare autonomous artificial intelligence (AI) company formerly known as IDx, announces it has acquired 3Derm Systems, Inc. of Boston, MA. This acquisition makes Digital Diagnostics the global leader in healthcare autonomous AI, where it is the sole holder of autonomous AI healthcare systems that are De Novo authorized by the U.S. Food & Drug Administration (FDA), enabling the company to close more care gaps widened by COVID-19. Read Full Release
Boston Millennia Parters
Cecelia Health Completes $13 Million Series B Financing to Transform Lives of People Living with Diabetes and Other Chronic Conditions
08.13.20
Cecelia Health, a leading technology-enabled diabetes and other chronic disease management company, announced today it has completed a $13 million Series B funding round. The investment was co-led by Rittenhouse Ventures and Endo Investors, and includes investments from Boston Millennia Partners, SustainVC, G100 Capital, and others. The funding will enable the company to accelerate and further scale the adoption of the company's technology enabled coaching and telemedicine solutions and expand Cecelia Health’s digital health capabilities. Read Full Release
TrekIT Health Raises $1M in Seed Funding
07.28.20
TrekIT Health, a Philadelphia, PA-based company re-designing the EHR experience for clinicians through predictive data visualization and modern clinical workflow tools, closed $1M in additional seed financing. The round was led by Tech Council Ventures with participation from Boston Millennia Partners Founders Fund and Front Row Fund, who joined existing investors including IP Group, DreamIT Health and Ben Franklin Technology Partners of Southeastern PA. Read Full Release
COTA Supports FDA Assessment of Real-World Data through Membership in COVID-19 Evidence Accelerator
06.10.20
COTA, Inc., a healthcare technology company that uses real-world data (RWD) to bring clarity to cancer care, is pleased to announce a number of initiatives that are bringing enhanced understanding of COVID-19 in near real-time. Leveraging its past knowledge of real-world evidence applications and learnings, COTA has joined the COVID-19 Evidence Accelerator program, a joint initiative of Friends of Cancer Research (Friends) and the Reagan-Udall Foundation for the Food and Drug Administration. Through this initiative, COTA is delivering findings from its observational, real-world studies using data from over 3,000 patients hospitalized with COVID-19 within the Hackensack Meridian Health network. Read Full Release
BC Platforms and Kaiser Permanente Win 2020 Microsoft Health Innovation Award for Precision Medicine Collaboration
05.19.20
BC Platforms and Kaiser Permanente today announced they are winners of the 2020 Microsoft Health Innovation Award in the Reimagine Health Category for enabling a unique way of pairing clinical and genomic data on the same platform to advance precision medicine capabilities. Read Full Release